LAD-I News
Latest articles and news about LAD-I on AXL Media.
Latest Articles
- FDA Approves Landmark Gene Therapy for Severe LAD-I After Successful UCLA-Led Clinical Trials
Published: Mar 28, 2026
Section: Health
The U.S. Food and Drug Administration has approved Kresladi, the first-ever gene therapy for leukocyte adhesion deficiency-I (LAD-I), a rare and often fatal pediatric immune disord...
- FDA Grants Landmark Approval to Kresladi as First Gene Therapy for Rare Pediatric Immune Disorder LAD-I
Published: Mar 28, 2026
Section: Health
The U.S. Food and Drug Administration has approved Kresladi, a groundbreaking one-time gene therapy developed by Rocket Pharmaceuticals and UCLA researchers for Leukocyte Adhesion...